Prevalence of hepatic abnormalities in a cohort of Egyptian children with type 1 diabetes mellitus

Pediatric Diabetes

Volumn 11, Issue 7, 2010, Pages 462-470

  El Karaksy, Hanaa Mostafa ^a   Anwar, Ghada ^a   Esmat, Gamal ^a   Mansour, Samah ^a   Sabry, Magda ^b   Helmy, Heba ^a   El Hennawy, Ahmad ^a   Fouad, Hanan ^b  

^a CAIRO UNIVERSITY   (Egypt)

^b NATIONAL HEPATOLOGY AND TROPICAL MEDICINE RESEARCH INSTITUTE   (Egypt)

Author keywords

Children; Egypt; Glycogenic hepatopathy; HCV; T1DM

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ANTINUCLEAR ANTIBODY; ASPARTATE AMINOTRANSFERASE; AZATHIOPRINE; BILIRUBIN; BIOLOGICAL MARKER; CORTICOSTEROID; ENDOMYSIUM ANTIBODY; GAMMA GLUTAMYLTRANSFERASE; GLIADIN ANTIBODY; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HEPATITIS A ANTIBODY; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MICROSOME ANTIBODY; MITOCHONDRION ANTIBODY; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY; SMOOTH MUSCLE ANTIBODY; TRIACYLGLYCEROL; VIRUS RNA;

ADOLESCENT; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOIMMUNE HEPATITIS; BILIRUBIN BLOOD LEVEL; CELIAC DISEASE; CHILD; CHILDHOOD DISEASE; CLINICAL EXAMINATION; COHORT ANALYSIS; CORTICOSTEROID THERAPY; CROSS-SECTIONAL STUDY; ECHOGRAPHY; EGYPT; FEMALE; FOLLOW UP; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; GLYCOGEN STORAGE DISEASE; HEPATITIS A; HEPATITIS A VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HEPATOMEGALY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; LIVER BIOPSY; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; PATIENT COUNSELING; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; PROTHROMBIN TIME; RISK FACTOR; SCHOOL CHILD; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ALANINE TRANSAMINASE; BLOOD GLUCOSE; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; EGYPT; FEMALE; HEPATITIS C; HEPATITIS C ANTIBODIES; HEPATOMEGALY; HUMANS; INFANT; LIVER; LIVER DISEASES; MALE; PREVALENCE;

EID: 77958601221     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2009.00627.x     Document Type: Article

References (35)

1. Atabek ME, Kart H, Erkul I. Prevalence of hepatitis A, B, C and E virus in adolescents with type-1 diabetes mellitus. Int J Adolesc Med Health 2003: 15: 133-137.
2. Sangiorgio L, Attardo T, Gangemi R, Rubino C, Barone M, Lunetta M. Increased frequency of HCV and HBV infection in type 2 diabetic patients. Diabetes Res Clin Pract 2000: 48: 147-151.
3. Cadranel JF, Di Martino V, Lambrey G et al. Prevalence of hepatitis C infection and risk factors in hospitalized diabetic patients: results of a cross-sectional study. Eur J Gastroenterol Hepatol 2008: 20: 829-836.
4. Simó R, Hernández C, Genescà J, Jardí R, Mesa J. High prevalence of hepatitis C virus infection in diabetic patients. Diabetes Care 1996: 19: 998-1000.
5. Mason AL, Lau JY, Hoang N et al. Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999: 29: 328-333.
6. Hudacko RM, Manoukian AV, Schneider SH, Fyfe B. Clinical resolution of glycogenic hepatopathy following improved glycemic control. J Diabetes Complications 2008: 22: 329-330.
7. Torbenson M, Chen YY, Brunt E et al. Glycogenic hepatopathy: an under recognized hepatic complication of diabetes mellitus. Am J Surg Pathol 2006: 30: 508-513.
8. Paradis V, Bedossa P. Definition and natural history of metabolic steatosis: histology and cellular aspects. Diabetes Metab 2008: 34: 638-642.
9. Munns CF, Mccrossin RB, Thomsett MJ, Batch J. Hepatic glycogenosis: reversible hepatomegaly in type 1 diabetes. J Paediatr Child Health 2000: 36: 449-452.
10. Van Steenbergen W, Lanckmans S. Liver disturbances in obesity and diabetes mellitus. Int J Obes Relat Metab Disord 1995: 19: 27-36.
11. International Society for Pediatric and Adolescent Diabetes (ISPAD) consensus guidelines for the management of type 1 diabetes mellitus in children and adolescents; 2002. Available from: (Accessed 12/01/2007).
12. Elbache N. Increased prevalence rate of diabetes mellitus and associated risk factors in the Arab world. Diabetes Metab 2003: 29: 457-464.
13. Medhat A, Shehata M, Magder LS et al. Hepatitis C in a community in Upper Egypt: risk factors for infection. Am J Trop Med Hyg 2002: 66: 633-638.
14. Habib M, Mohamed MK, Abdel-Aziz F et al. Hepatitis C virus infection in a community in the Nile Delta: risk factors for seropositivity. Hepatology 2001: 33: 248-253.
15. Balter S, Layton M, Bornschlegel K et al. Transmission of hepatitis B and C viruses in outpatient settings - New York, Oklahoma and Nebraska, 2000-2002. MMWR 2003; 52: 901-906.
16. Desenclos JC, Bourdiol-Razès M, Rolin B et al. Hepatitis C in a ward for cystic fibrosis and diabetic patients: possible transmission by spring-loaded finger-stick devices for self monitoring of capillary blood glucose. Infect Control Hosp Epidemiol 2001: 22: 701-707.
17. American Diabetes Association (ADA). Standards of medical care in diabetes. Diabetes care 2004: 27: 15-35.
18. Centers for Disease Control and Prevention (CDC). Transmission of hepatitis B and C viruses in outpatient settings - New York, Oklahoma and Nebraska, 2000-2002. MMWR 2002: 52: 901-906.
19. El-Raziky MS, El-Hawary M, Esmat G et al. Prevalence and risk factors of asymptomatic hepatitis C virus infection in Egyptian children. World J Gastroenterol 2007: 13: 1828-1832.
20. Bhattacharya S, Badrinath S, Hamide A, Sujatha S. Co-infection with hepatitis C virus and human immunodeficiency virus among patients with sexually transmitted diseases in Pondicherry, South India. Indian J Pathol Microbiol 2003: 46: 495-497.
21. Hyder SN, Hussain W, Aslam M, Maqbool S. Seroprevalence of anti-HCV in asymptomatic children. Pak Pediatr J 2001: 25: 89-93.
22. Khan HI. A study of seroprevalence of hepatitis B and C in mothers and children in Lahore. Pak Pediatr J 1996: 20: 163-166.
23. El-Nawawy AA, El-Azzouni OF, Soliman AT, Amer AE, Demian RS, El- Sayed HM. Prevalence of hepatitis-C antibody seropositivity in healthy Egyptian children and four high risk groups. J Trop Pediatr 1995: 41: 341-343.
24. Cerutti F, Palomba E, Sacchetti C, Gay V, Versace A, Tovo PA. Anti-HCV antibodies in a population of insulin-dependent diabetic children and adolescents. Diabetes Care 1999: 22: 1587-1588.
25. El-Raziky MS, El-Hawary M, El-Koofy N et al. Hepatitis C virus infection in Egyptian children: single centre experience. J Viral Hepat 2004: 11: 471-476.
26. Jara P, Resti M, Hierro L. Chronic hepatitis C virus infection in childhood: clinical patterns and evolution in 224 white children. Clin Infect Dis 2003: 36: 275-280.
27. Franchini M, Rossetti G, Tagliaferri A. The natural history of chronic hepatitis C in a cohort of HIV-negative Italian patients with hereditary bleeding disorders. Blood 2001: 98: 1836-1841.
28. Centers for Disease Control and Prevention (CDC). Surveillance for acute viral hepatitis - United States, 2005. MMWR Surveill Summ 2007: 56: 1-24.
29. Takaike H, Uchigata Y, Iwasaki N, Iwamoto Y. Transient elevation of liver transaminase after starting insulin therapy for diabetic ketosis or ketoacidosis in newly diagnosed type 1 diabetes mellitus. Diabetes Res Clin Pract 2004: 64: 27-32.
30. Attar BM, Halliburton C, Chinga-Alayo E. Correlation of ultrasonography and histology in patients with steatosis. Gastroenterology 2006: 130: 590-595.
31. Chatila R, West AB. Hepatomegaly and abnormal liver tests due to glycogenosis in adults with diabetes. Medicine (Baltimore) 1996: 75: 327-333.
32. Choudhuri G, Somani SK, Baba CS, Alexander G. Autoimmune hepatitis in India: profile of an uncommon disease. Gastroenterology 2005: 15: 5-27.
33. Liu E, Bao F, Barriga K, Miao D, Yu LP, Erlich HA. Fluctuating transglutaminase autoantibodies are related to histologic features of celiac disease. Clin Gastroenterol Hepatol 2003: 1: 356-362.
34. Stevens FM, Mcloughlin RM. Is celiac disease a potentially treatable cause of liver failure? Eur J Gastroentrol Hepatol 2005: 17: 1119-1121.
35. Duggan JM, Duggan AE. Systemic review: the liver in celiac disease. Aliment Pharmacol Ther 2005: 21: 515-518.